Resultados de la búsqueda 81-90 of 2842 for ☄캐나다커뮤니티 임마누엘 뉴저지커뮤니티☄

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Although survivorship recommendations have been developed in areas such as lymphoma and stem cell transplant, the long-term effects of CAR-T therapy are ...

  2. Hematología - Ensayos clínicos - Mayo Clinic

    Rochester, Minn., Scottsdale/Phoenix, Ariz. This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The pupose of this study is to evaluate whether or not selumetinib works just as well as the standard treatment with carboplatine/vincristine (CV) for ...

  5. Hematología - Ensayos clínicos - Mayo Clinic

    This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.

  7. Salud del adulto - Mayo Clinic

    Cancer and the LGBTQ+ community: Mayo Clinic expert addresses key topics June 20, 2023, 03:30 p.m. CDT · The importance of prioritizing mental health for the ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The primary objective of this proposal is to develop a Thoracic Specimen Registry at Mayo Clinic. The purpose of the registry will be to support ongoing ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is for IMC-F106C plus nivolumab compared to standard nivolumab regimens in HLA-A*02:01-positive participants with previously untreated ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...